Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial | Zendy

Javed Butler | Zendy; Gerasimos Filippatos | Zendy; Tariq Jamal Siddiqi | Zendy; Martina Brueckmann | Zendy; Michael Böhm | Zendy; Vijay Chopra | Zendy; João Pedro Ferreira | Zendy; James L. Januzzi | Zendy; Sanjay Kaul | Zendy; Ileana L. Piña | Zendy; Piotr Ponikowski | Zendy; Sanjiv J. Shah | Zendy; Michele Senni | Zendy; Ola Vedin | Zendy; Subodh Verma | Zendy; Barbara Peil | Zendy; Stuart J. Pocock | Zendy; Faı̈ez Zannad | Zendy; Milton Packer | Zendy; Stefan D. Anker | Zendy

Open Access

Empagliflozin, Health Status, and Quality of Life in Patients With Heart Failure and Preserved Ejection Fraction: The EMPEROR-Preserved Trial

Author(s) -

Javed Butler,

Gerasimos Filippatos,

Tariq Jamal Siddiqi,

Martina Brueckmann,

Michael Böhm,

Vijay Chopra,

João Pedro Ferreira,

James L. Januzzi,

Sanjay Kaul,

Ileana L. Piña,

Piotr Ponikowski,

Sanjiv J. Shah,

Michele Senni,

Ola Vedin,

Subodh Verma,

Barbara Peil,

Stuart J. Pocock,

Faı̈ez Zannad,

Milton Packer,

Stefan D. Anker

Publication year - 2021

Publication title -

circulation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 7.795

H-Index - 607

eISSN - 1524-4539

pISSN - 0009-7322

DOI - 10.1161/circulationaha.121.057812

Subject(s) - medicine , empagliflozin , ejection fraction , heart failure , emperor , cardiology , quality of life (healthcare) , clinical trial , intensive care medicine , nursing , ancient history , diabetes mellitus , endocrinology , history , type 2 diabetes mellitus

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research